Cargando…

CXCR4-directed theranostics in oncology and inflammation

Given its prominent role in inflammation and cancer biology, the C-X-C motif chemokine receptor 4 (CXCR4) has gained a lot of attention in the recent years. This review gives a short overview of the physiology and pathology of chemokines and chemokine receptors and then focuses on the current experi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kircher, Malte, Herhaus, Peter, Schottelius, Margret, Buck, Andreas K., Werner, Rudolf A., Wester, Hans-Jürgen, Keller, Ulrich, Lapa, Constantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182637/
https://www.ncbi.nlm.nih.gov/pubmed/30105558
http://dx.doi.org/10.1007/s12149-018-1290-8
_version_ 1783362612170326016
author Kircher, Malte
Herhaus, Peter
Schottelius, Margret
Buck, Andreas K.
Werner, Rudolf A.
Wester, Hans-Jürgen
Keller, Ulrich
Lapa, Constantin
author_facet Kircher, Malte
Herhaus, Peter
Schottelius, Margret
Buck, Andreas K.
Werner, Rudolf A.
Wester, Hans-Jürgen
Keller, Ulrich
Lapa, Constantin
author_sort Kircher, Malte
collection PubMed
description Given its prominent role in inflammation and cancer biology, the C-X-C motif chemokine receptor 4 (CXCR4) has gained a lot of attention in the recent years. This review gives a short overview of the physiology and pathology of chemokines and chemokine receptors and then focuses on the current experience of targeting CXCR4, using radiolabeled receptor ligands suitable for positron emission tomography (PET) imaging, in both hematologic and solid malignancy as well as in inflammatory conditions. Additionally, CXCR4-directed endoradiotherapy (ERT) as a new treatment option is discussed.
format Online
Article
Text
id pubmed-6182637
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-61826372018-10-24 CXCR4-directed theranostics in oncology and inflammation Kircher, Malte Herhaus, Peter Schottelius, Margret Buck, Andreas K. Werner, Rudolf A. Wester, Hans-Jürgen Keller, Ulrich Lapa, Constantin Ann Nucl Med Invited Review Article Given its prominent role in inflammation and cancer biology, the C-X-C motif chemokine receptor 4 (CXCR4) has gained a lot of attention in the recent years. This review gives a short overview of the physiology and pathology of chemokines and chemokine receptors and then focuses on the current experience of targeting CXCR4, using radiolabeled receptor ligands suitable for positron emission tomography (PET) imaging, in both hematologic and solid malignancy as well as in inflammatory conditions. Additionally, CXCR4-directed endoradiotherapy (ERT) as a new treatment option is discussed. Springer Japan 2018-08-13 2018 /pmc/articles/PMC6182637/ /pubmed/30105558 http://dx.doi.org/10.1007/s12149-018-1290-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Invited Review Article
Kircher, Malte
Herhaus, Peter
Schottelius, Margret
Buck, Andreas K.
Werner, Rudolf A.
Wester, Hans-Jürgen
Keller, Ulrich
Lapa, Constantin
CXCR4-directed theranostics in oncology and inflammation
title CXCR4-directed theranostics in oncology and inflammation
title_full CXCR4-directed theranostics in oncology and inflammation
title_fullStr CXCR4-directed theranostics in oncology and inflammation
title_full_unstemmed CXCR4-directed theranostics in oncology and inflammation
title_short CXCR4-directed theranostics in oncology and inflammation
title_sort cxcr4-directed theranostics in oncology and inflammation
topic Invited Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182637/
https://www.ncbi.nlm.nih.gov/pubmed/30105558
http://dx.doi.org/10.1007/s12149-018-1290-8
work_keys_str_mv AT kirchermalte cxcr4directedtheranosticsinoncologyandinflammation
AT herhauspeter cxcr4directedtheranosticsinoncologyandinflammation
AT schotteliusmargret cxcr4directedtheranosticsinoncologyandinflammation
AT buckandreask cxcr4directedtheranosticsinoncologyandinflammation
AT wernerrudolfa cxcr4directedtheranosticsinoncologyandinflammation
AT westerhansjurgen cxcr4directedtheranosticsinoncologyandinflammation
AT kellerulrich cxcr4directedtheranosticsinoncologyandinflammation
AT lapaconstantin cxcr4directedtheranosticsinoncologyandinflammation